LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Return
10.14%
This Quarter Return
-2.72%
1 Year Return
+10.14%
3 Year Return
+35.76%
5 Year Return
+141%
10 Year Return
–
AUM
$1.08B
AUM Growth
-$23.9M
(-2.2%)
Cap. Flow
+$19.9M
Cap. Flow
% of AUM
1.83%
Top 10 Holdings %
Top 10 Hldgs %
44.12%
Holding
2,984
New
204
Increased
1,436
Reduced
716
Closed
196
Top Buys
| 1 |
Technology Select Sector SPDR Fund
XLK
|
+$4.5M |
| 2 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$4.22M |
| 3 |
RPAR Risk Parity ETF
RPAR
|
+$2.61M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$2.52M |
| 5 |
Financial Select Sector SPDR Fund
XLF
|
+$1.95M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.86M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.34M |
| 3 |
CHI
Calamos Convertible Opportunities and Income Fund
CHI
|
+$2.29M |
| 4 |
Coinbase
COIN
|
+$2.13M |
| 5 |
PepsiCo
PEP
|
+$2.1M |
Sector Composition
| 1 | Technology | 16.5% |
| 2 | Financials | 11.63% |
| 3 | Healthcare | 5.47% |
| 4 | Consumer Discretionary | 4.35% |
| 5 | Communication Services | 4.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HUT
2401
Hut 8
HUT
$3.37B
| $1.28K | ﹤0.01% |
110
-11
| -9% | -$128 |
|
2402
RxSight
RXST
$385M
| $1.26K | ﹤0.01% |
+50
| New | +$1.26K |
|
2403
Spyre Therapeutics
SYRE
$978M
| $1.26K | ﹤0.01% |
+78
| New | +$1.26K |
|
2404
Compass Minerals
CMP
$771M
| $1.25K | ﹤0.01% |
135
-23
| -15% | -$214 |
|
2405
Radware
RDWR
$1.12B
| $1.25K | ﹤0.01% |
58
| – | – |
|
2406
Enhabit
EHAB
$411M
| $1.24K | ﹤0.01% |
141
+24
| +21% | +$211 |
|
2407
XPEL
XPEL
$993M
| $1.23K | ﹤0.01% |
42
+29
| +223% | +$852 |
|
2408
ePlus
PLUS
$1.99B
| $1.22K | ﹤0.01% |
20
+12
| +150% | +$733 |
|
|
TWO
2409
Two Harbors Investment
TWO
$1.05B
| $1.22K | ﹤0.01% |
91
+32
| +54% | +$428 |
|
2410
EverQuote
EVER
$903M
| $1.21K | ﹤0.01% |
+46
| New | +$1.21K |
|
2411
SFL Corp
SFL
$1.1B
| $1.21K | ﹤0.01% |
147
-283
| -66% | -$2.32K |
|
2412
Navient
NAVI
$1.31B
| $1.2K | ﹤0.01% |
95
+20
| +27% | +$253 |
|
2413
Cullinan Oncology
CGEM
$391M
| $1.2K | ﹤0.01% |
158
-133
| -46% | -$1.01K |
|
2414
Arteris
AIP
$381M
| $1.2K | ﹤0.01% |
+173
| New | +$1.2K |
|
2415
KBR
KBR
$6.38B
| $1.2K | ﹤0.01% |
24
-66
| -73% | -$3.29K |
|
2416
PDF Solutions
PDFS
$789M
| $1.19K | ﹤0.01% |
62
+11
| +22% | +$210 |
|
2417
Instil Bio
TIL
$161M
| $1.18K | ﹤0.01% |
68
| – | – |
|
2418
CG Oncology
CGON
$2.53B
| $1.18K | ﹤0.01% |
+48
| New | +$1.18K |
|
|
BBBY
2419
Bed Bath & Beyond, Inc.
BBBY
$607M
| $1.17K | ﹤0.01% |
+201
| New | +$1.17K |
|
2420
Fidelis Insurance
FIHL
$1.83B
| $1.17K | ﹤0.01% |
+72
| New | +$1.17K |
|
2421
Evolv Technologies
EVLV
$1.37B
| $1.16K | ﹤0.01% |
372
+240
| +182% | +$749 |
|
2422
Golden Entertainment
GDEN
$649M
| $1.16K | ﹤0.01% |
44
| – | – |
|
2423
Vericel Corp
VCEL
$1.69B
| $1.16K | ﹤0.01% |
26
+14
| +117% | +$625 |
|
2424
Target Hospitality
TH
$889M
| $1.16K | ﹤0.01% |
176
+116
| +193% | +$763 |
|
2425
IES Holdings
IESC
$7.48B
| $1.16K | ﹤0.01% |
7
| – | – |
|